HSD17B6 - Hsd17b6 hydroxysteroid (17-beta) dehydrogenase 6 Gene
Also Known as Hsd17b9
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 286964
Summary
Enables steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Predicted to be involved in brexanolone catabolic process. Predicted to be located in endoplasmic reticulum membrane. Predicted to be integral component of membrane. Orthologous to human HSD17B6 (hydroxysteroid 17-beta dehydrogenase 6). [provided by Alliance of Genome Resources, Apr 2022]
HSD17B6 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_173305.2 | NP_775427.2 | 17-beta-hydroxysteroid dehydrogenase type 6 |
| Molecular Function GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| enables androstan-3-alpha,17-beta-diol dehydrogenase activity |
IDA
IDA: Inferred from direct assay
|
9188497 | RGD |
| enables androsterone dehydrogenase activity |
IDA
IDA: Inferred from direct assay
|
9188497 | RGD |
| enables estradiol 17-beta-dehydrogenase [NAD(P)+] activity |
IDA
IDA: Inferred from direct assay
|
9188497 | RGD |
| enables testosterone dehydrogenase (NAD+) activity |
IDA
IDA: Inferred from direct assay
|
9188497 | RGD |
EXP: Inferred from Experiment
IDA: Inferred from direct assay
IPI: Inferred from physical interaction
IMP: Inferred from mutant phenotype
IGI: Inferred from genetic interaction
IEP: Inferred from expression pattern
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
17-beta-hydroxysteroid dehydrogenase type 6 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(1)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS06398 | HSD17B6 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service